Taking 60 mg of melatonin is extremely unlikely to kill you or send you to the emergency room, but calling it “safe” would be misleading. That dose is roughly 100 to 200 times what the body produces on its own each night, and it far exceeds the 0.5 to 5 mg range most sleep researchers consider reasonable for everyday use. Researchers have given patients doses well above 60 mg in clinical studies, sometimes for months or years, and while acute poisoning has never been documented even at far higher amounts, that does not mean the dose is risk-free. There are real concerns about hormonal disruption, metabolic changes, receptor desensitization, and in at least one trial, liver injury.
Why 60 mg Won’t Kill You, but That’s a Low Bar
Melatonin has an unusually wide margin between a “normal” dose and a lethal one. No human lethal dose has ever been established because researchers have never been able to push the hormone to a point where it causes organ failure or death. A case report published in 2024 described a patient who took roughly 900 mg of melatonin in a single acute ingestion. The person remained stable, experienced only sedation, and recovered without lasting effects. The same report noted that chronic daily doses of 1,000 mg in adults produced no observable toxicity.1PubMed Central. Case report on melatonin overdose: Cause and concern In pharmacological terms, 60 mg barely registers on the scale of what has been tested. But surviving a dose is not the same as that dose being harmless over time.
Melatonin clears the body quickly. In older adults given oral doses, peak blood levels arrived within about an hour and a half, and the hormone’s half-life was around two hours. The pharmacokinetics follow a roughly linear pattern, meaning that if you take ten times the dose, your blood levels rise about tenfold rather than accumulating unpredictably.2PubMed Central. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults So even a 60 mg dose would largely be gone within eight to ten hours. That fast clearance is part of why acute toxicity is so rare. It also means the hormone is not building up in your system day after day the way a longer-acting drug might.
How Researchers Have Used Doses This High and Higher
A 60 mg dose sounds alarming if your frame of reference is the 3 or 5 mg gummies on drugstore shelves. But in several areas of medicine, researchers have deliberately pushed doses into this range and far beyond it, looking for effects that go well beyond sleep.
In ALS research, patients have received 300 mg of melatonin per day, administered rectally, for up to two years. That dose was described as well tolerated, and it brought down a blood marker of oxidative stress to levels seen in healthy controls.3PubMed. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment A later analysis using a large ALS database echoed that conclusion, noting that high doses up to 300 mg per day for two years appeared safe.4PubMed Central. Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open-Access ALS Clinic Trials database
In oncology, melatonin has been studied as an add-on to chemotherapy and radiation. Doses in these trials commonly fall in the range of 20 to 40 mg per day, though some go higher. The research has focused on whether melatonin can ease treatment side effects, reduce fatigue, improve sleep, and possibly strengthen the anticancer activity of conventional therapies.5PubMed Central. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities Observational data have linked melatonin use during cancer treatment to lower rates of chemotherapy-induced nerve damage and suppressed blood cell production, though most of this evidence comes from studies looking at quality-of-life markers rather than hard survival endpoints.6PubMed Central. Melatonin in Integrative Oncology: Biological Mechanisms, Therapeutic Evidence and Implementation Strategies
Sepsis is another area where high-dose melatonin has been explored. Across randomized controlled trials, doses have ranged from 6 mg up to 60 mg per day.7Complementary Therapies in Medicine. Efficacy of melatonin as adjunctive therapy for sepsis: A meta-analysis of randomized controlled trials In a pharmacokinetic study of critically ill sepsis patients given 50 mg of oral melatonin, there were no incidents of vomiting, diarrhea, changes in clinical parameters, or other acute effects in the 24 hours after dosing.8PubMed Central. Dose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsis A separate randomized trial in early septic shock patients found no adverse events attributable to melatonin over a five-day treatment period.9PubMed Central. A pilot study on the melatonin treatment in patients with early septic shock: results of a single-center randomized controlled trial
A study of elderly patients with sleep problems and multiple health conditions prescribed daily melatonin at a mean dose of about 73 mg (ranging from 40 to 200 mg) reported no clinically relevant adverse effects, with only occasional headache or dizziness. Interestingly, this same group showed statistically significant decreases in hypertension, heart disease, and diabetes rates during treatment.10PubMed Central. Rethinking Melatonin Dosing: Safety and Efficacy at Higher-than-Usual Levels in Aged Patients with Sleep Disturbances and Comorbidities These are encouraging signals, but they come from observational or open-label studies, not the kind of large controlled trials that would establish safety with real confidence.
Where the Safety Picture Gets Complicated
The “no lethal dose” framing can create a false sense that melatonin at any amount is basically harmless. Several findings push back on that idea.
The most striking safety signal comes from a 2025 randomized trial testing high-dose melatonin alongside ocrelizumab in people with progressive multiple sclerosis. Of the four patients randomized to receive melatonin, three women developed elevated liver enzymes within the first three months, serious enough that the trial was unblinded and stopped. The one male patient on melatonin showed no liver problems after 14 months, and none of the four placebo patients had any comparable liver abnormalities.11PubMed Central. Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1) The sample was tiny, and the patients were on another powerful drug simultaneously, so it is hard to know whether the melatonin or the combination was responsible. But the fact that a trial was halted for liver toxicity at all is a reminder that melatonin’s safety profile at high doses is not fully mapped, and may not be the same for everyone.
A case report described a patient receiving a combination of risperidone and high-dose melatonin who developed breast tissue growth (breast budding) after one month. The changes reversed when melatonin was discontinued.12PubMed Central. Combination Therapy With Risperidone and High-Dose Melatonin Is Effective Despite Reversible Side Effects Including Breast Budding That kind of hormonal effect is not entirely surprising given what is known about how melatonin influences the body’s reproductive hormone system. Melatonin acts on the hypothalamic-pituitary-gonadal axis, the hormonal chain that governs sex hormones, and high concentrations can shift the balance of those signals.13Clinica Chimica Acta. Melatonin and male reproduction
What Happens to Your Melatonin Receptors at High Doses
Your brain’s melatonin receptors are not designed for pharmacological-level flooding. There are two main receptor types involved in melatonin’s effects on the body clock, and they respond differently to sustained high exposure.
When MT2 receptors are exposed to even physiological concentrations of melatonin for a period mimicking a normal night (about eight hours), they desensitize, reducing the clock’s responsiveness to the melatonin signal. Supraphysiological concentrations cause a more persistent desensitization: after exposure to higher levels, full receptor recovery took longer than 24 hours, meaning the receptors were still partially blunted the next night.14PubMed. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin MT1 receptors show a different pattern. At supraphysiological concentrations, the number of MT1 receptors on cell surfaces actually increases, but the receptors become functionally desensitized anyway, meaning they are present but less responsive.15PubMed. Melatonin-mediated regulation of human MT(1) melatonin receptors expressed in mammalian cells
The practical concern here is that taking a dose like 60 mg every night could progressively dull the very system you are trying to activate. Your clock hardware stays intact, but the software becomes less responsive. This could explain anecdotal reports from long-term high-dose users who feel the melatonin stops working or who struggle with sleep even more after stopping. Reassuringly, one study found that a 50 mg daily dose given for 37 days to a blind subject did not suppress or alter the body’s own melatonin production pattern.16PubMed. The amplitude of endogenous melatonin production is not affected by melatonin treatment in humans So melatonin likely does not permanently damage the pineal gland’s ability to make the hormone on its own, even if receptor sensitivity shifts.
The Insulin Sensitivity Problem
One of the less-discussed risks of taking melatonin at any dose, but especially at high doses, involves how the hormone interacts with your body’s handling of blood sugar. A randomized, placebo-controlled crossover trial found that three months of melatonin treatment significantly reduced insulin sensitivity in patients with type 2 diabetes.17PubMed Central. Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes—A randomized placebo‐controlled crossover trial Lab studies on human fat tissue showed that melatonin dampened insulin signaling, particularly in the evening, by downregulating the insulin signaling pathway at the gene-expression level.18PubMed. Melatonin decreases human adipose tissue insulin sensitivity
This makes biological sense. Melatonin is a darkness hormone: its natural job is to signal nighttime, when the body is supposed to be fasting. Reducing insulin sensitivity during the night is part of that program. The trouble arises when you swallow a large dose of melatonin and then eat, or when the elevated melatonin levels persist into morning hours and overlap with breakfast. Genetic variation in the melatonin receptor gene MTNR1B is already recognized as a risk factor for impaired fasting glucose and type 2 diabetes, adding another layer to this relationship.19PubMed Central. Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy For someone already dealing with prediabetes or diabetes, a dose as high as 60 mg deserves extra caution, particularly around when they eat relative to when they take it.
Why Children Are a Separate Conversation
If 60 mg poses uncertain risks for adults, the stakes are higher for children. Between 2012 and 2021, poison control centers in the United States recorded over 260,000 pediatric melatonin ingestions, with the annual number rising by 530% over the decade. Hospitalizations and serious outcomes climbed along with the numbers. Five children required mechanical ventilation, and two died.20PubMed Central. Pediatric Melatonin Ingestions – United States, 2012-2021 Most of these cases involved unintentional ingestion by children under five, often from flavored gummy products left within reach.
Part of the issue is biological. The liver enzyme primarily responsible for breaking down melatonin, CYP1A2, develops gradually. In infants aged 3 to 12 months, CYP1A2 activity is only about 30% of the adult level, and in children aged 1 to 9 years, it is around 50%.21Kosin Medical Journal. Safety issues regarding melatonin use in child and adolescent patients with sleep problems That means a given dose produces higher blood levels and lasts longer in a small child than the same dose per kilogram would in an adult. A bottle of high-dose gummies accidentally consumed by a toddler is a genuine medical emergency, even if the same absolute amount would be trivial for a grown adult.
Drug Interactions and CYP1A2
That same liver enzyme, CYP1A2, is the primary pathway through which your body breaks down melatonin, and any drug that inhibits it can effectively turn a moderate dose into a much larger one in your bloodstream. In a screening study of potential interactions, the potent CYP1A2 inhibitor 5-methoxypsoralen (used in some skin treatments) impaired melatonin breakdown at clinically relevant concentrations, while common drugs like diazepam, tamoxifen, and acetaminophen did not significantly interfere.22Physiology & Behavior. Potential drug interactions with melatonin Fluvoxamine, a well-known CYP1A2 inhibitor prescribed for OCD and anxiety, is probably the most commonly encountered drug that can dramatically raise melatonin levels. Caffeine is also metabolized by CYP1A2, which is why heavy coffee drinkers and non-coffee drinkers may experience the same dose of melatonin quite differently.
CBD, which many people take alongside melatonin in combined supplement products, also inhibits CYP1A2-mediated melatonin metabolism. In vitro data showed that CBD acted as both a competitive and mechanism-based inhibitor of human CYP1A2, meaning it not only blocks the enzyme temporarily but can partially inactivate it.23PubMed Central. Unraveling Cannabidiol’s Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections If you are already taking 60 mg of melatonin and you add CBD, the effective dose your body experiences could be substantially higher than what you swallowed.
Melatonin’s Antioxidant Activity at Pharmacological Doses
Part of the rationale behind giving patients doses of 60 mg and above is that melatonin and its breakdown products are strong free radical scavengers. At pharmacological concentrations, melatonin and its metabolites neutralize both reactive oxygen and nitrogen species through multiple pathways: directly scavenging free radicals, stimulating the body’s own antioxidant enzymes, suppressing pro-oxidant enzymes, and stabilizing mitochondria.24PubMed Central. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions This is why high-dose melatonin keeps showing up in research on conditions driven by oxidative damage, from ALS to sepsis to radiation injury.
There is an ironic twist, though. In some cell-culture studies, melatonin at very high concentrations promoted the generation of free radicals rather than suppressing them, particularly in certain tumor cell lines. Whether this pro-oxidant effect translates to humans at any realistic dose is unclear, but it raises the question of whether you can have too much of a good antioxidant, at least in certain tissues.
Sleep Quality and Next-Day Function
If you are considering 60 mg because lower doses haven’t helped you sleep, the research on dose-response for sleep is actually sobering. A study comparing a physiological dose of 0.3 mg to 5 mg found that the lower dose mainly improved sleep during the biological day, while 5 mg increased sleep efficiency during both day and night, largely by extending lighter sleep stages and slightly shortening awakenings.25PubMed Central. High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults The gains from 5 mg over 0.3 mg were real but not dramatic, and the jump from 5 mg to 60 mg has not been shown to produce proportionally bigger improvements in sleep architecture. What likely happens instead is more sedation, heavier drowsiness the next morning, and the receptor desensitization described earlier.
A meta-analysis of melatonin’s effects on cognitive function in healthy adults found that daytime melatonin did not impair memory or reaction time overall, but it did significantly decrease accuracy on tasks.26Neuroscience & Biobehavioral Reviews. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials That was with typical study doses, not 60 mg. With a dose that large, the hormone lingers longer and at higher levels, making next-morning grogginess and impaired performance a practical concern, especially for anyone who needs to drive or operate machinery early.
The Supplement Label Problem
An underappreciated dimension of this question is whether the 60 mg on the label is actually 60 mg in the bottle. In the United States, melatonin is sold as a dietary supplement, meaning it is not subject to pharmaceutical-grade quality control. Previous analyses have found wide discrepancies between labeled and actual content. A 2025 European analysis of melatonin supplements found that actual melatonin content ranged from 71% to 182% of the labeled amount across products in the legal supply chain.27PubMed Central. Validated UHPLC Methods for Melatonin Quantification Reveal Regulatory Violations in EU Online Dietary Supplements Commerce The U.S. market, with its higher typical doses and less stringent regulation than the EU, has historically shown similar or wider variability. If you are taking a product labeled at 60 mg and it contains 182% of the labeled amount, you are actually swallowing closer to 109 mg.
This is not a hypothetical worry for someone already pushing into high-dose territory. At 3 mg, the difference between 71% and 182% of the label is a few milligrams. At 60 mg, that same proportional spread covers a range of roughly 43 to 109 mg, which is a meaningfully different exposure for your liver, your insulin response, and your melatonin receptors. If you are going to take high-dose melatonin for any reason, choosing a product that has been independently tested for actual content is more important than it would be at conventional doses.